# Boston Scientific vs Cigna Group: stocks compared

URL: https://funkfolio.com/compare/bsx-vs-ci

> Boston Scientific ($62.4B, P/E 18.5) and Cigna Group ($77.5B, P/E 13.2) compared: size, valuation, margins, debt, cash and price change.

---

## Boston Scientific vs Cigna Group

Boston Scientific (BSX), health care, and Cigna Group (CI), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Cigna Group is worth $77.5B on the stock market and Boston Scientific $62.4B: Cigna Group is valued at 24% more. Boston Scientific trades at 18.5 times earnings and Cigna Group at 13.2; operating margins in their latest fiscal years were 18.0% and 3.35%. Over the past year Boston Scientific's share price has moved -56.0% and Cigna Group's +10.1%.

### Key facts

- **Boston Scientific market value:** $62.4B
- **Cigna Group market value:** $77.5B
- **Boston Scientific P/E:** 18.5
- **Cigna Group P/E:** 13.2
- **Boston Scientific revenue:** $20.1B FY to 2025-12-31
- **Cigna Group revenue:** $274.9B FY to 2025-12-31
- **Superinvestors holding both:** 4

Market values as of 18 Nov 2026, 04:26 UTC.

Boston Scientific vs Cigna Group: every measure side by side

| Measure | Boston Scientific | Cigna Group |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $62.4B lower | $77.5B higher |
| Revenue | $20.1B lower | $274.9B higher |
| Earnings | $2.9B lower | $6B higher |
| Employees | 59,000 lower | 65,669 higher |
| Total assets | $43.7B lower | $157.9B higher |
| Valuation |  |  |
| P/E | 18.5 higher | 13.2 lower |
| P/S | 3.1 higher | 0.3 lower |
| P/B | 2.4 higher | 1.8 lower |
| Dividend yield | 0.00% lower | 2.06% higher |
| Profitability |  |  |
| Operating margin | 18.0% higher | 3.35% lower |
| Balance sheet |  |  |
| Net assets | $24.2B lower | $41.7B higher |
| Total liabilities | $19.2B lower | $116B higher |
| Total debt | $11.4B lower | $31.5B higher |
| Cash on hand | $2B lower | $7.7B higher |
| Price change |  |  |
| Today | -1.51% higher | -2.03% lower |
| 1 year | -56.0% lower | +10.1% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Boston Scientific 42.3, Cigna Group 108.4.

- Boston Scientific (BSX)
- Cigna Group (CI)

Boston Scientific and Cigna Group share prices over one year, rebased to 100: Boston Scientific ends at 42.3, Cigna Group at 108.4.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | BSX | CI |
| --- | --- | --- |
| Nov 28, 2025 | 99.8 | 102.2 |
| Dec 31, 2025 | 93.7 | 101.4 |
| Jan 30, 2026 | 91.9 | 101.0 |
| Feb 27, 2026 | 75.5 | 106.8 |
| Mar 31, 2026 | 61.7 | 98.3 |
| Apr 30, 2026 | 56.6 | 107.1 |
| May 29, 2026 | 47.5 | 102.2 |
| Jun 30, 2026 | 41.9 | 101.6 |
| Jul 31, 2026 | 45.9 | 102.8 |
| Aug 31, 2026 | 47.5 | 101.8 |
| Sep 30, 2026 | 42.9 | 100.2 |
| Oct 30, 2026 | 41.3 | 109.9 |
| Nov 17, 2026 | 42.3 | 108.4 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (4)

- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.8% / 0.8%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.6% / 0.3%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 0.3% / 1.8%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 0.1% / 2.3%

#### Boston Scientific only (9)

- [Andrew Spokes](https://funkfolio.com/gurus/farallon) 2.6%
- [Lee Ainslie](https://funkfolio.com/gurus/lee-ainslie) 2.3%
- [Primecap team](https://funkfolio.com/gurus/primecap) 1.6%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 1.2%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.7%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.4%
- [Temasek](https://funkfolio.com/gurus/temasek) 0.3%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.3%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.1%

#### Cigna Group only (11)

- [Anthony Bozza](https://funkfolio.com/gurus/anthony-bozza) 6.0%
- [Andrew Wellington](https://funkfolio.com/gurus/andrew-wellington) 2.8%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 2.7%
- [Christopher Davis](https://funkfolio.com/gurus/christopher-davis) 2.7%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.7%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 1.5%
- [David Einhorn](https://funkfolio.com/gurus/david-einhorn) 0.6%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.4%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.3%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.2%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Boston Scientific / Cigna Group). [Who owns BSX](https://funkfolio.com/stock/BSX/superinvestors) · [Who owns CI](https://funkfolio.com/stock/CI/superinvestors)

### More on Boston Scientific

- [Boston Scientific (BSX) stock page](https://funkfolio.com/stock/BSX)
- [Boston Scientific market cap](https://funkfolio.com/stock/BSX/market-cap)
- [Boston Scientific revenue](https://funkfolio.com/stock/BSX/revenue)
- [Boston Scientific P/E ratio](https://funkfolio.com/stock/BSX/pe-ratio)
- [Boston Scientific operating margin](https://funkfolio.com/stock/BSX/operating-margin)
- [Boston Scientific total debt](https://funkfolio.com/stock/BSX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Cigna Group

- [Cigna Group (CI) stock page](https://funkfolio.com/stock/CI)
- [Cigna Group market cap](https://funkfolio.com/stock/CI/market-cap)
- [Cigna Group revenue](https://funkfolio.com/stock/CI/revenue)
- [Cigna Group P/E ratio](https://funkfolio.com/stock/CI/pe-ratio)
- [Cigna Group operating margin](https://funkfolio.com/stock/CI/operating-margin)
- [Cigna Group total debt](https://funkfolio.com/stock/CI/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Boston Scientific against its closest peers

- [Boston Scientific vs Cardinal Health](https://funkfolio.com/compare/bsx-vs-cah)
- [Boston Scientific vs Cencora](https://funkfolio.com/compare/bsx-vs-cor)
- [Boston Scientific vs Takeda Pharmaceutical](https://funkfolio.com/compare/bsx-vs-tak)
- [Boston Scientific vs argenx](https://funkfolio.com/compare/argx-vs-bsx)

#### Cigna Group against its closest peers

- [Cigna Group vs Elevance Health](https://funkfolio.com/compare/ci-vs-elv)
- [Cigna Group vs Takeda Pharmaceutical](https://funkfolio.com/compare/ci-vs-tak)
- [Cigna Group vs Cencora](https://funkfolio.com/compare/ci-vs-cor)
- [Cigna Group vs Regeneron Pharmaceuticals](https://funkfolio.com/compare/ci-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Boston Scientific or Cigna Group?**

By market value, Cigna Group is the larger: $77.5B against $62.4B for Boston Scientific. By revenue in its latest fiscal year, Cigna Group is the larger: $274.9B against $20.1B for Boston Scientific.

**Which has the higher P/E ratio?**

Boston Scientific: 18.5, against 13.2 for Cigna Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Boston Scientific: 18.0%, against 3.35% for Cigna Group. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Cigna Group: 2.06%, against 0.00% for Boston Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Cigna Group: $31.5B, against $11.4B for Boston Scientific. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Boston Scientific and Cigna Group?**

In their latest 13F filings, Louis Bacon, John Overdeck and David Siegel (founders), Dodge & Cox team and Larry Robbins hold both.

### Cite this page

Funkfolio, “Boston Scientific vs Cigna Group”, data as of 18 November 2026. https://funkfolio.com/compare/bsx-vs-ci

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
